Guest Open Access Plus | Free Content | About | Sign in | New Users: Sign up | Mark List  

Current Angiogenesis

Volume 1 Issue 3
ISSN: 2211-5528
eISSN: 2211-5536

 

   All Titles

  PPARγ in Angiogenesis and Vascular Development
  pp.192-205 (14) Author: David S. Milstone
doi: 10.2174/2211552811201030192
 
 
      Abstract

In recent years several molecular and cellular mechanisms have been elucidated that regulate angiogenesis and vascular development. As a result some therapeutic interventions are now available with the potential to enhance normal vascular development and/or to modulate vascular-based disease. The nuclear hormone receptor PPARγ and its clinically useful pharmacologic ligands also modulate angiogenesis and vascular development by actions on both endothelial cells and other cell types. This involves specific effects on the molecular interaction partners and target genes of PPARγ, compensatory changes in processes primarily regulated by other proteins including other PPAR family members, coactivators and corepressors, and “off target” effects involving other signaling pathways. Despite this progress, several factors interfere with determining the specific functions of PPARγ in blood vessel formation and thus with developing PPARγ-based strategies to modulate angiogenesis and vascular development for therapeutic benefit. This review summarizes current proposals for PPARγ functions in angiogenesis and vascular development and emphasizes the complexity of PPARγ gene expression, molecular isoforms with unique functions and unknown expression patterns, the paucity of physiologically relevant endogenous ligands, uncertainties about the specificity of exogenous ligands, and the complex molecular interactions of PPARγ with coregulators and other modifiers. These features are likely responsible for many of the conflicting results obtained in studies of PPARγ in blood vessels and other tissues. Considering these challenges suggests new experimental approaches and future scientific directions that should support significant benefits in a variety of clinical settings involving angiogenesis and vascular development.

 
  Keywords: Angiogenesis, vascular development, peroxisome proliferator activated receptor gamma, endothelium, isoform, placenta
  Affiliation: Center for Excellence in Vascular Biology, Vascular Research Division, Department of Pathology, Brigham&Women's Hospital, Harvard New Research Building 730-G, 77 Avenue Louis Pasteur, Boston, MA 02115, USA.
 
  Key: New Content Free Content Open Access Plus Subscribed Content

Bentham Science Publishers
www.benthamscience.com

 

  Copyright © 1994 - 2014   Bentham Science Publishers